Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1961 1
1978 1
1983 1
1985 2
1986 1
1990 1
1991 4
1992 2
1993 1
1994 1
1995 2
1996 3
1997 1
1998 3
1999 2
2000 2
2001 9
2002 5
2003 2
2005 2
2006 1
2007 1
2008 1
2012 1
2013 2
2014 1
2015 5
2016 2
2017 1
2018 2
2019 6
2020 5
2021 3
2022 6
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.
Matsubayashi H, Oishi T, Sasaki K, Abe M, Kiyozumi Y, Higashigawa S, Niiya F, Sato J, Ishiwatari H, Imai K, Hotta K, Kishida Y, Takada K, Ono H, Yamazaki K, Yasui H, Kenmotsu H, Kado N, Kagawa H, Shiomi A, Sugiura T, Bando E, Nishimura S, Hatakeyama K, Serizawa M, Harada R, Sugino T. Matsubayashi H, et al. Among authors: kado n. Hum Pathol. 2023 May;135:54-64. doi: 10.1016/j.humpath.2022.12.016. Epub 2022 Dec 31. Hum Pathol. 2023. PMID: 36596344
Endometriosis: the pathophysiology as an estrogen-dependent disease.
Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Kitawaki J, et al. Among authors: kado n. J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):149-55. doi: 10.1016/s0960-0760(02)00260-1. J Steroid Biochem Mol Biol. 2002. PMID: 12650711 Review.
Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
Onuki M, Takahashi F, Iwata T, Nakazawa H, Yahata H, Kanao H, Horie K, Konnai K, Nio A, Takehara K, Kamiura S, Tsuda N, Takei Y, Shigeta S, Matsumura N, Yoshida H, Motohara T, Yamazaki H, Nakamura K, Hamanishi J, Tasaka N, Ishikawa M, Hirashima Y, Kudaka W, Mori-Uchino M, Kukimoto I, Fujii T, Watanabe Y, Noda K, Yoshikawa H, Yaegashi N, Matsumoto K; MINT Study Group. Onuki M, et al. Cancer Sci. 2023 Nov;114(11):4426-4432. doi: 10.1111/cas.15943. Epub 2023 Sep 8. Cancer Sci. 2023. PMID: 37688310 Free PMC article.
Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients.
Matsubayashi H, Todaka A, Kawakami T, Hamauchi S, Yokota T, Higashigawa S, Kiyozumi Y, Harada R, Kado N, Nishimura S, Ishiwatari H, Sato J, Niiya F, Ono H, Sugiura T, Sasaki K, Yasui H, Yamazaki K. Matsubayashi H, et al. Among authors: kado n. J Hum Genet. 2023 Feb;68(2):81-86. doi: 10.1038/s10038-022-01097-y. Epub 2022 Dec 8. J Hum Genet. 2023. PMID: 36482120
86 results